Skip to content
Back Home
  • Home
  • About Us
    • Our History
    • Our Science
    • Our Partners
  • Scientific Platforms
    • ADCs
    • Publications
  • Team
  • News
  • Contact
Back Home
  • Search
  • Home
  • About Us
    • Our History
    • Our Science
    • Our Partners
  • Scientific Platforms
    • ADCs
    • Publications
  • Team
  • News
  • Contact
Home » Uncategorized » Manhattan BioSolutions establishes new laboratory space at the JLabs JNJ Innovation incubator in New York City
Uncategorized

Manhattan BioSolutions establishes new laboratory space at the JLabs JNJ Innovation incubator in New York City

by Mbio2018|Published November 1, 2018

You may also like

Published November 7, 2023

Manhattan BioSolutions Enters Into Collaboration Agreements with the NIH and Binghamton University to Develop Novel ADC

Collaboration with National Institutes of Health and Binghamton University to Develop Novel Antibody-Drug Conjugates for Pediatric Cancer https://www.issuewire.com/manhattan-biosolutions-enters-into-collaboration-agreements-with-the-nih-and-binghamton-university-to-develop-novel-adc-1781455477718844 New York City, New […]

Published June 25, 2024

Manhattan BioSolutions Partners to Advance Taxoids as Innovative ADC Payloads

Published August 26, 2020

EVQLV and Manhattan BioSolutions Enter into Strategic Collaboration to Discover Novel Antibody-Based Therapies

New York, NY August 25, 2020—EVQLV, Inc., an artificial intelligence-enabled technology company accelerating biologics discovery, announced today a strategic research collaboration with […]

Published April 8, 2025

Manhattan BioSolutions Secures Expanded Rights to Novel Legumain-Cleavable Topoisomerase 1 Inhibitor (TOP1i) ADC Platform After Successful Multi-Target Validation

Post navigation

  • Previous post Manhattan BioSolutions has been awarded Phase 1 SBIR Grant from the National Cancer Institute, National Institute Of Health
  • Back to post list
  • Next post Nascent Biotech and Manhattan BioSolutions Enter into Collaboration to Advance Vaccine Discovery and Development for COVID-19

© 2025 Manhattan BioSolutions – All rights reserved

Powered by WP – Designed with the Customizr theme